Sign in
Home
Biotech Insights
Biotech News
CEO Interviews
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in / Join
About Us
Privacy Policy
Disclaimer
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
Biotech Insights
Biotech News
CEO Interviews
CEO Interviews
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
CEO Interviews
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
CEO Interviews
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
CEO Interviews
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
BioTechStockTrader
About Biotech Stocktrader
Alernative Pharma
Biotech Insights
Biotech News
CEO Interviews
COVID-19
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over $10 Million from Exercise of...
Paul Archie
-
March 2, 2021
0
Big Pharma Dives Into CBD: Who Could Be Next?
Paul Archie
-
February 22, 2021
0
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
Paul Archie
-
December 22, 2020
0
Biotech News
Home
Biotech News
Page 22
Biotech News
BSGM: PURE EP Launch Timing Aligns Well With Attractive Market Fundamentals
BiotechStocktrader
-
October 26, 2018
0
Biotech News
Innovus Pharma Announces Planned Expansion into CBD Oil-Based Products Market
BiotechStocktrader
-
October 22, 2018
0
Biotech News
BioSig Technologies Begins Trading on Nasdaq
BiotechStocktrader
-
September 21, 2018
0
Biotech News
BioSig Technologies (BSGM) PT Raised to $12.50 at Chardan Ahead of...
BiotechStocktrader
-
September 20, 2018
0
1
...
20
21
22
Page 22 of 22
- Advertisement -
APPLE
INmune Bio Announces Positive Alzheimer’s Disease Trial Data, Stock Doubles
Andrew M.
-
July 16, 2020
0
Biotech Insights
Shares of INmune Bio (NASDAQ:INMB) more than doubled on July 14th following the company's announcement of positive Phase 1b data on XPro1595 for patients...
RECENT POSTS
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over...
Paul Archie
-
March 2, 2021
Big Pharma Dives Into CBD: Who Could Be Next?
Paul Archie
-
February 22, 2021
Clinical Trials Focus on COVID-19 and Acute Myocarditis
Paul Archie
-
January 19, 2021
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
Paul Archie
-
December 22, 2020
